Jun Zou

7.7k total citations
53 papers, 1.2k citations indexed

About

Jun Zou is a scholar working on Molecular Biology, Computational Theory and Mathematics and Information Systems. According to data from OpenAlex, Jun Zou has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Computational Theory and Mathematics and 9 papers in Information Systems. Recurrent topics in Jun Zou's work include Computational Drug Discovery Methods (12 papers), Recommender Systems and Techniques (7 papers) and Protein Structure and Dynamics (5 papers). Jun Zou is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Recommender Systems and Techniques (7 papers) and Protein Structure and Dynamics (5 papers). Jun Zou collaborates with scholars based in China, United States and Switzerland. Jun Zou's co-authors include Shengyong Yang, Yuquan Wei, Faramarz Fekri, Linli Li, Haixia Qi, Huanzhang Xie, Melvyn S. Tockman, Hong Tang, Robert A. Clark and Lihua Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jun Zou

51 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jun Zou

Since Specialization

Citations

This map shows the geographic impact of Jun Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Zou more than expected).

Fields of papers citing papers by Jun Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Zou. The network helps show where Jun Zou may publish in the future.

Co-authorship network of co-authors of Jun Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Zou. A scholar is included among the top collaborators of Jun Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Zou. Jun Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small‐molecule drugs as RNA‐targeted degraders 2023 ·SHILAP Revista de lepidopterología ·Luyi Huang, Jun Zou	1
2	Lipid metabolism dysfunction induced by age-dependent DNA methylation accelerates aging 2022 ·Signal Transduction and Targeted Therapy ·Xin Li, Jiaqiang Wang, (unknown), Yuanxu Gao, Guihai Feng, Gen Li, Jun Zou, (unknown), (unknown), Chao Liu, (unknown), Ling Zhao, Hong Ouyang, Jian‐Kang Zhu, Wei Li, Qi Zhou, Kang Zhang	76
3	Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1 2022 ·Nature Chemical Biology ·Xin Yang, Xuehui Wang, Zheng Xu, Chao Wu, Yangli Zhou, Yifei Wang, Guifeng Lin, (unknown), Ming Wu, Anjie Xia, Jingming Liu, Lin Cheng, Jun Zou, Wei Yan, Zhenhua Shao, Shengyong Yang	67
4	Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor 2022 ·Nature Communications ·Yueshan Li, (unknown), Yifei Wang, Jun Zou, Ruicheng Yang, (unknown), Chengyong Wu, Wei Yang, Chenyu Tian, (unknown), Falu Wang, Xin Yang, Linli Li, Shengyong Yang	55
5	Evaluation of neuroprotective agents acting via the BDNF–TrkB pathway using AI‐enabled predictions of ligand–receptor interactions 2022 ·SHILAP Revista de lepidopterología ·Jing Zhu, Jun Zou, Fei Li, Yuanxu Gao, Lijun Wang, Yi Eve Sun, Jie Zhu, Xiaomeng Zhang, (unknown), Kanmin Xue, Gen Li, (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Clinical efficacy of Lopinavir-Ritonavir combined with interferon alpha in COVID-19 2021 ·(unknown), Tao Suo, Huaying Fan, Kailiang Zhao, Jun Zou, Depei Wu, Guofang Tang, (unknown)	0
7	Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic 2020 ·Asian Spine Journal ·Jun Zou, Hao Yu, Dawei Song, Junjie Niu, Huilin Yang	36
8	Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers 2020 ·Frontiers in Pharmacology ·Yiwei Wang, Lei Huang, (unknown), Yifei Wang, Jun Zou, Hongguang Fu, Shengyong Yang	36
9	CapsCarcino: A novel sparse data deep learning tool for predicting carcinogens 2019 ·Food and Chemical Toxicology ·Yiwei Wang, Lei Huang, (unknown), Kan Li, Jun Zou, Shengyong Yang	37
10	Exploiting Popularity and Similarity for Link Recommendation in Twitter Networks 2014 ·Conference on Recommender Systems ·Jun Zou, Faramarz Fekri	3
11	¹H NMR-based metabolic profiling of human rectal cancer tissue 2013 ·Molecular Cancer ·Huijuan Wang, Liang Wang, Hailong Zhang, Pengchi Deng, (unknown), Bin Zhou, Jing Hu, Jun Zou, Wenjie Lu, Xiang Pu, Tianming Wu, Xiaoni Shao, Yuan Li, Zong‐Guang Zhou, Yinglan Zhao	91
12	Neighbor communities in drug combination networks characterize synergistic effect 2012 ·Molecular BioSystems ·Jun Zou, (unknown), Yinglan Zhao, Linli Li, Yuquan Wei, Yu Chen, Shengyong Yang	31
13	Discovery of Novel Bruton’s Tyrosine Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approaches Based on SVM Model, Pharmacophore and Molecular Docking 2012 ·Chemical Biology & Drug Design ·(unknown), (unknown), Linli Li, (unknown), (unknown), Jingjing Liu, Hui Zhang, Jun Zou, Shengyong Yang	12
14	Identification of Novel Anaplastic Lymphoma Kinase (ALK) Inhibitors Using a Common Feature Pharmacophore Model Derived from Known Ligands Crystallized with ALK 2012 ·Chemical Biology & Drug Design ·Huanzhang Xie, (unknown), (unknown), Jun Zou, (unknown), Linli Li, Qi Huang, Hui Zhang, Shengyong Yang	2
15	Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization 2012 ·European Journal of Medicinal Chemistry ·Lingling Yang, Guo‐Bo Li, Hengxiu Yan, Qizheng Sun, Shuang Ma, (unknown), Zerong Wang, Shan Feng, Jun Zou, Shengyong Yang	39
16	Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry 2010 ·Molecular BioSystems ·Jun Zou, (unknown), Yuquan Wei, Shengyong Yang	12
17	Pharmacophore modeling study based on known Spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Huanzhang Xie, Linli Li, Ji-Xia Ren, Jun Zou, Yang Li, Yuquan Wei, Shengyong Yang	34
18	Detailed conformational dynamics of juxtamembrane region and activation loop in c‐Kit kinase activation process 2008 ·Proteins Structure Function and Bioinformatics ·Jun Zou, (unknown), (unknown), Mingli Xiang, Bing Shi, Yuquan Wei, Shengyong Yang	23
19	Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2 2008 ·Journal of Molecular Graphics and Modelling ·Jun Zou, Huanzhang Xie, Shengyong Yang, (unknown), Ji-Xia Ren, Yuquan Wei	58
20	Protease domain of human ADAM33 produced by Drosophila S2 cells 2004 ·Protein Expression and Purification ·W.W. Prosise, T. Yarosh-Tomaine, (unknown), Richard Ingram, Jun Zou, Jianjun Liu, Feng Zhu, S. Shane Taremi, Hung V. Le, Wenyan Wang	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Swainston Breakdown of academic impact, for papers by Kirill Degtyarenko Breakdown of academic impact, for papers by Paul D. Dobson Breakdown of academic impact, for papers by Xuan Hong Breakdown of academic impact, for papers by Juan Liu Breakdown of academic impact, for papers by Jennifer Fostel Breakdown of academic impact, for papers by Anna Gambin Breakdown of academic impact, for papers by Thomas Kelder